Cargando…

Psychiatrists' Attitudes toward Metabolic Adverse Events in Patients with Schizophrenia

BACKGROUND: There is growing concern about the metabolic abnormalities in patients with schizophrenia. AIMS: The aim of this study was to assess the attitudes of psychiatrists toward metabolic adverse events in patients with schizophrenia. METHOD: A brief questionnaire was constructed to cover the f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugawara, Norio, Yasui-Furukori, Norio, Yamazaki, Manabu, Shimoda, Kazutaka, Mori, Takao, Sugai, Takuro, Suzuki, Yutaro, Someya, Toshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900677/ https://www.ncbi.nlm.nih.gov/pubmed/24466260 http://dx.doi.org/10.1371/journal.pone.0086826

Ejemplares similares

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2016)

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2020)

High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey
por: Sugai, Takuro, et al.
Publicado: (2015)

High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey
por: Sugai, Takuro, et al.
Publicado: (2016)

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey
por: Ono, Shin, et al.
Publicado: (2018)

Projections of psychiatrists’ distribution for patients in Japan: a utilization-based approach
por: Sugawara, Norio, et al.
Publicado: (2021)

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
por: Kawamata, Yasushi, et al.
Publicado: (2021)

Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine?
por: Sugawara, Norio, et al.
Publicado: (2021)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Factor structure of the University Personality Inventory in Japanese medical students
por: Sugawara, Norio, et al.
Publicado: (2020)

Item response theory analysis of the University Personality Inventory in medical students
por: Sugawara, Norio, et al.
Publicado: (2023)

Relationship Between Cognitive Functions and Decision-Making Capacity in Older Institutionalized Patients with Schizophrenia: A Preliminary Study
por: Sugawara, Norio, et al.
Publicado: (2022)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
por: Okayasu, Hiroaki, et al.
Publicado: (2021)

Prevalence of perinatal depression among Japanese women: a meta-analysis
por: Tokumitsu, Keita, et al.
Publicado: (2020)

Prevalence of perinatal depression among Japanese men: a meta-analysis
por: Tokumitsu, Keita, et al.
Publicado: (2020)

Working status of caregivers for people with dementia: Analysis data from a Japanese Nationwide Survey
por: Sugawara, Norio, et al.
Publicado: (2020)

Blood Levels of Ammonia and Carnitine in Patients Treated with Valproic Acid: A Meta-analysis
por: Yokoyama, Saaya, et al.
Publicado: (2022)

Survey of Health Literacy Among Japanese Outpatients with Mental Illness
por: Sato, Yoshiteru, et al.
Publicado: (2023)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2019)

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2019)

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff
por: Tarakita, Natsumi, et al.
Publicado: (2018)

Dietary patterns are associated with obesity in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2015)

Body mass index and quality of life among outpatients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2013)

PM399. Attitudes toward antipsychotic long-acting injections among patients with Schizophrenia in Japan.
por: Kudo, Shuhei, et al.
Publicado: (2016)

Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia
por: Tajiri, Misuzu, et al.
Publicado: (2018)

Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia
por: Yamada, Momoka, et al.
Publicado: (2023)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga, Koji, et al.
Publicado: (2015)

A pregnant woman who experienced auditory hallucinations concurrent with hyperemesis gravidarum: A case report
por: Okayasu, Hiroaki, et al.
Publicado: (2021)

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2011)

Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years
por: Yasui-Furukori, Norio, et al.
Publicado: (2023)

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2014)

Parental bonding and attitudes toward suicide among medical college students in Japan
por: Hashimoto, Kojiro, et al.
Publicado: (2014)

Body composition in patients with schizophrenia: Comparison with healthy controls
por: Sugawara, Norio, et al.
Publicado: (2012)

Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia
por: Ito, Satsuki, et al.
Publicado: (2023)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
por: Sugawara, Norio, et al.
Publicado: (2020)

Update on the development of lurasidone as a treatment for patients with acute schizophrenia
por: Yasui-Furukori, Norio
Publicado: (2012)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto, Kojiro, et al.
Publicado: (2014)

A case of musical hallucinations induced by tramadol
por: Hase, Tatsu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_83lkpqq0r4ld8teoa7hr6usftu